Soleto, I.; Ramirez, C.; Gómez, C.; Baldan-Martin, M.; Orejudo, M.; Mercado, J.; Chaparro, M.; Gisbert, J.P.
Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease. Biomedicines 2023, 11, 2831.
https://doi.org/10.3390/biomedicines11102831
AMA Style
Soleto I, Ramirez C, Gómez C, Baldan-Martin M, Orejudo M, Mercado J, Chaparro M, Gisbert JP.
Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease. Biomedicines. 2023; 11(10):2831.
https://doi.org/10.3390/biomedicines11102831
Chicago/Turabian Style
Soleto, Irene, Cristina Ramirez, Cristina Gómez, Montse Baldan-Martin, Macarena Orejudo, Jorge Mercado, MarÃa Chaparro, and Javier P. Gisbert.
2023. "Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease" Biomedicines 11, no. 10: 2831.
https://doi.org/10.3390/biomedicines11102831
APA Style
Soleto, I., Ramirez, C., Gómez, C., Baldan-Martin, M., Orejudo, M., Mercado, J., Chaparro, M., & Gisbert, J. P.
(2023). Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease. Biomedicines, 11(10), 2831.
https://doi.org/10.3390/biomedicines11102831